Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Photochem Photobiol Sci. 2013 Jan;12(1):16-21. doi: 10.1039/c2pp25120e.
Over many centuries, treatment with sunlight or "heliotherapy" was used in the treatment of skin diseases. More than 3500 years ago, ancient Egyptian and Indian healers used the ingestion of plant extracts or seeds in addition to sunlight for treating "leucoderma". Modern phototherapy began with Nobel Prize winner Niels Finsen who developed a "chemical rays" lamp with which he treated patients with skin tuberculosis. However, it took several decades until phototherapy was introduced anew into the dermatological armamentarium. It was the development of photochemotherapy (PUVA) in 1974 that marked the beginning of a huge upsurge in photodermatology. The subsequent development of high intensity UV sources with defined spectra facilitated an optimized therapy for psoriasis and led to an expansion of indications for photo(chemo)therapy also in combination with topical and systemic agents. The introduction of extracorporeal photopheresis in 1987 for cutaneous T-cell lymphoma and of topical photodynamic therapy widely expanded the therapeutic possibilities in dermato-oncology.
几个世纪以来,阳光治疗或“日光疗法”一直被用于治疗皮肤病。早在 3500 多年前,古埃及和印度的治疗师就已经在使用阳光的同时,还内服植物提取物或种子来治疗“白癜风”。现代光疗始于诺贝尔奖得主尼尔斯·芬森,他开发了一种“化学射线”灯,并用它来治疗皮肤结核患者。然而,光疗在皮肤科领域的应用又过了几十年才重新出现。1974 年光化学疗法(PUVA)的发展标志着光皮肤病学的巨大热潮的开始。随后,高强度、具有特定光谱的紫外线光源的发展促进了对银屑病的优化治疗,并扩大了光(化学)疗法的适应证,也包括与局部和全身药物联合应用。1987 年,体外光分离术被引入用于治疗皮肤 T 细胞淋巴瘤,以及广泛应用的局部光动力疗法,极大地扩展了皮肤科肿瘤学的治疗可能性。